Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 4.371
Filter
1.
Anim Biotechnol ; 35(1): 2404043, 2024 Nov.
Article in English | MEDLINE | ID: mdl-39306701

ABSTRACT

Mammalian embryos often suffer from oxidative stress in vitro, as the oxygen in the atmosphere is higher than that in the oviductal environment. Vitamin C (Vc) has been proven to enhance early embryonic development in vitro, but the underlying mechanism remains unclear. In this study, we investigated the pathways of action by which Vc promotes the in vitro development of porcine embryos. Comparative analysis of in vitro and in vivo gene expression profiles of morula found that most of the differentially expressed genes were enriched in pathways related to mitochondrial function. The addition of 12.5 µg/mL Vc to the culture medium significantly increased blastocyst production in a dose- and duration-dependent manner. Moreover, ROS levels were significantly higher in embryos cultured in the air (21% oxygen) than cultured in a hypoxic condition (5% oxygen) and were reduced by Vc supplementation. Vc also significantly increased the mitochondrial membrane potential levels and the expression levels of mitochondrial function-related genes (MFN1 and OPA1) and TCA cycle-related genes (PDHA1 and OGDH) in embryos cultured in vitro. These results suggest that the addition of Vc to the in vitro culture medium can increase the developmental potential and improve the mitochondrial function of early porcine embryos.


Subject(s)
Ascorbic Acid , Embryo Culture Techniques , Embryonic Development , Membrane Potential, Mitochondrial , Mitochondria , Animals , Ascorbic Acid/pharmacology , Swine/embryology , Mitochondria/drug effects , Embryonic Development/drug effects , Embryo Culture Techniques/veterinary , Membrane Potential, Mitochondrial/drug effects , Blastocyst/drug effects , Reactive Oxygen Species/metabolism , Culture Media/chemistry , Culture Media/pharmacology , Gene Expression Regulation, Developmental/drug effects , Female , Embryo, Mammalian/drug effects
2.
Epigenomics ; 16(15-16): 1117-1127, 2024.
Article in English | MEDLINE | ID: mdl-39140401

ABSTRACT

DNA methylation is closely related to folate levels and acts as a mechanism linking developmental disorders to chronic diseases. Folic acid supplementation can impact DNA methylation levels of imprinted genes crucial for neonatal development. Imprinted genes are vital for regulating embryonic and postnatal fetal growth. This review summarizes imprinted genes, DNA methylation, folic acid's influence on growth and development and their correlation. It aims to provide a comprehensive overview of research advancements on imprinted genes, DNA methylation and folic acid regulation concerning growth and development.


[Box: see text].


Subject(s)
DNA Methylation , Folic Acid , Genomic Imprinting , Growth and Development , Folic Acid/metabolism , Folic Acid/pharmacology , Embryo, Mammalian/drug effects , Embryo, Mammalian/embryology , Humans , Female , Pregnancy , Animals , Epigenesis, Genetic , Growth and Development/drug effects , Growth and Development/physiology
3.
Methods Mol Biol ; 2818: 133-145, 2024.
Article in English | MEDLINE | ID: mdl-39126471

ABSTRACT

Oogenesis is the central process required to produce viable oocytes in female mammals. It is initiated during embryonic development, and it involves the specification of primordial germ cells (PGCs) and progresses through the activation of the meiotic program, reaching a crucial phase in prophase I before pausing at diplotene around the time of birth. The significance of meiosis, particularly the prophase I stage, cannot be overstated, as it plays a pivotal role in ensuring the formation of healthy gametes, a prerequisite for successful reproduction. While research has explored meiosis across various organisms, understanding how environmental factors, including radiation, drugs, endocrine disruptors, reproductive age, or diet, influence this complex developmental process remains incomplete. In this chapter, we describe an ex vivo culture method to investigate meiotic prophase I and beyond and the disruption of oogenesis by external factors. Using this methodology, it is possible to evaluate the effects of individual xenobiotics by administering chemicals at specific points during oogenesis. This culture technique was optimized to study the effects of two selected endocrine disruptors (vinclozolin and MEHP), demonstrating that vinclozolin exposure delayed meiotic differentiation and MEHP exposure reduced follicle size. This approach also opens avenues for future applications, involving the exploration of established or novel pharmaceutical substances and their influence on essential events during prophase I, such as homologous recombination and chromosome segregation. These processes collectively dictate the ultimate fitness of oocytes, with potential implications for factors relevant to the reproductive age and fertility.


Subject(s)
Meiosis , Ovary , Animals , Female , Mice , Ovary/cytology , Meiosis/drug effects , Oogenesis/drug effects , Oocytes/cytology , Oocytes/drug effects , Meiotic Prophase I/drug effects , Endocrine Disruptors/pharmacology , Oxazoles/pharmacology , Embryo, Mammalian/cytology , Embryo, Mammalian/drug effects
4.
Reprod Biomed Online ; 49(4): 104120, 2024 10.
Article in English | MEDLINE | ID: mdl-39084124

ABSTRACT

RESEARCH QUESTION: To what extent does the type and concentration of protein and the type of culture medium affect the sensitivity of the mouse embryo assay (MEA) to detect Triton X-100 (TX-100) in culture media? DESIGN: The effect of the concentration of bovine serum albumin (BSA) and human serum albumin (HSA) was assessed by supplementing media with 0.5 or 5 mg/ml. Potassium-supplemented simplex optimized medium (KSOM) and human tubal fluid (HTF) were used as complex and simple formulation media, respectively. Variables were combined, forming study groups where embryos were cultured in test media spiked with a sublethal TX-100 concentration. The conditions of greatest sensitivity were determined by statistical comparison of blastocyst formation rates and total cell counts between groups. RESULTS: Although all of the study groups showed equal capacity for sustaining proper embryo development, the reported sensitivity of the MEA differed between groups when subjected to TX-100. HTF conferred significantly greater sensitivity than KSOM regardless of the type and concentration of protein used, and medium supplementation with 5 mg/ml BSA rather than 0.5 mg/ml BSA resulted in significantly higher sensitivity regardless of the type of medium used. This increase in concentration also resulted in higher sensitivity when supplementing HTF with HSA. The BSA groups provided more sensitivity than their HSA counterparts, except for the KSOM + 0.5 mg/ml BSA group. Cell count analysis did not provide further significant conclusions. CONCLUSIONS: For TX-100 detection within culture medium, the type and concentration of protein and the type of culture medium have a direct effect on MEA sensitivity. These results could help to standardize the MEA protocol, and increase its ability to detect sublethal concentrations of embryotoxic substances, especially TX-100, thus avoiding possible clinical harmful effects.


Subject(s)
Culture Media , Embryo Culture Techniques , Embryonic Development , Octoxynol , Serum Albumin, Bovine , Octoxynol/pharmacology , Animals , Mice , Serum Albumin, Bovine/pharmacology , Embryo Culture Techniques/methods , Female , Embryonic Development/drug effects , Embryo, Mammalian/drug effects , Humans , Serum Albumin, Human/analysis
5.
Tissue Cell ; 89: 102480, 2024 Aug.
Article in English | MEDLINE | ID: mdl-39029316

ABSTRACT

Success of animal cloning is limited by oocyte quality, which is closely linked to reprogramming ability. The number of layers of cumulus cells is typically used to assess the quality of oocyte; a minimum of one-third of collected cumulus-oocyte complexes (COCs) are discarded as inferior oocytes because they have less cumulus cells. Melatonin, which has been recognised for its ability to sequester free radicals and perform multiple functions, has emerged as a potentially effective candidate for enhancing inferior oocytes quality and, consequently, embryo development competency. The current study investigates to improve the quality of inferior oocytes by supplementation of melatonin (10-9 M) during in vitro maturation (IVM) and subsequent cloned embryo production and its mechanism. The results indicate that melatonin supplementation significantly (p<0.05) enhances inferior oocytes maturation, reduces oxidative stress by reducing ROS levels, and improves mitochondrial function by boosting GSH levels. The melatonin treatment (10-9 M) enhances the expression of SOD, GPx1, GDF 9, BMP 15, ATPase 6, and ATPase 8 in inferior oocytes. Furthermore, melatonin treatment increases the total cell number in the treated groups, promoting cloned blastocyst formation rates derived from inferior oocytes. Furthermore, compared to the control, 10-9 M melatonin supplementation enhances H3K9ac acetylation and lowers H3K27me3 methylation in cloned blastocysts derived from inferior oocytes. In conclusion, 10-9 M melatonin supplementation during IVM increased inferior oocyte maturation and promoted cloned buffalo embryo development by lowering oxidative stress and promoting epigenetic alterations. These studies show that melatonin may improve the quality of poor oocytes and buffalo cloning.


Subject(s)
Buffaloes , Epigenesis, Genetic , In Vitro Oocyte Maturation Techniques , Melatonin , Oocytes , Melatonin/pharmacology , Animals , Buffaloes/embryology , Oocytes/drug effects , Oocytes/metabolism , Oocytes/cytology , Epigenesis, Genetic/drug effects , In Vitro Oocyte Maturation Techniques/methods , Female , Nuclear Transfer Techniques , Embryonic Development/drug effects , Cloning, Organism , Blastocyst/metabolism , Blastocyst/drug effects , Oxidative Stress/drug effects , Embryo, Mammalian/metabolism , Embryo, Mammalian/drug effects
6.
Biosci Biotechnol Biochem ; 88(9): 1064-1068, 2024 Aug 26.
Article in English | MEDLINE | ID: mdl-38936835

ABSTRACT

Depleting glutathione by xCT inhibition induces iron-dependent ferroptotic cell death, which is suppressed by lipophilic antioxidants. We screened food extracts with xCTKO-MEFs, identifying garlic extracts as particularly potent in inhibiting ferroptosis among the food extracts examined in this study. xCTKO-MEFs can serve as a convenient tool for identifying food extracts that are effective in inhibiting ferroptosis.


Subject(s)
Amino Acid Transport System y+ , Ferroptosis , Fibroblasts , Mice, Knockout , Plant Extracts , Ferroptosis/drug effects , Animals , Mice , Fibroblasts/drug effects , Fibroblasts/metabolism , Amino Acid Transport System y+/metabolism , Amino Acid Transport System y+/genetics , Amino Acid Transport System y+/antagonists & inhibitors , Plant Extracts/pharmacology , Glutathione/metabolism , Garlic/chemistry , Iron/metabolism , Antioxidants/pharmacology , Embryo, Mammalian/cytology , Embryo, Mammalian/drug effects
7.
Mol Cell Proteomics ; 23(7): 100797, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38866076

ABSTRACT

Targeted protein degradation is the selective removal of a protein of interest through hijacking intracellular protein cleanup machinery. This rapidly growing field currently relies heavily on the use of the E3 ligase cereblon (CRBN) to target proteins for degradation, including the immunomodulatory drugs (IMiDs) thalidomide, lenalidomide, and pomalidomide which work through a molecular glue mechanism of action with CRBN. While CRBN recruitment can result in degradation of a specific protein of interest (e.g., efficacy), degradation of other proteins (called CRBN neosubstrates) also occurs. Degradation of one or more of these CRBN neosubstrates is believed to play an important role in thalidomide-related developmental toxicity observed in rabbits and primates. We identified a set of 25 proteins of interest associated with CRBN-related protein homeostasis and/or embryo/fetal development. We developed a targeted assay for these proteins combining peptide immunoaffinity enrichment and high-resolution mass spectrometry and successfully applied this assay to rabbit embryo samples from pregnant rabbits dosed with three IMiDs. We confirmed previously reported in vivo decreases in neosubstrates like SALL4, as well as provided evidence of neosubstrate changes for proteins only examined in vitro previously. While there were many proteins that were similarly decreased by all three IMiDs, no compound had the exact same neosubstrate degradation profile as another. We compared our data to previous literature reports of IMiD-induced degradation and known developmental biology associations. Based on our observations, we recommend monitoring at least a major subset of these neosubstrates in a developmental test system to improve CRBN-binding compound-specific risk assessment. A strength of our assay is that it is configurable, and the target list can be readily adapted to focus on only a subset of proteins of interest or expanded to incorporate new findings as additional information about CRBN biology is discovered.


Subject(s)
Proteolysis , Proteomics , Thalidomide , Ubiquitin-Protein Ligases , Animals , Rabbits , Proteomics/methods , Ubiquitin-Protein Ligases/metabolism , Thalidomide/analogs & derivatives , Thalidomide/pharmacology , Proteolysis/drug effects , Female , Embryo, Mammalian/metabolism , Embryo, Mammalian/drug effects , Adaptor Proteins, Signal Transducing/metabolism , Lenalidomide/pharmacology , Pregnancy
8.
Mol Biol Rep ; 51(1): 692, 2024 May 25.
Article in English | MEDLINE | ID: mdl-38796562

ABSTRACT

BACKGROUND: Resveratrol, a potent antioxidant, is known to induce the up-regulation of the internal antioxidant system. Therefore, it holds promise as a method to mitigate cryopreservation-induced injuries in bovine oocytes and embryos. This study aimed to (i) assess the enhancement in the quality of in vitro produced bovine embryos following resveratrol supplementation and (ii) monitor changes in the expression of genes associated with oxidative stress (GPX4, SOD, CPT2, NFE2L2), mitochondrial function (ATP5ME), endoplasmic reticulum function (ATF6), and embryo quality (OCT4, DNMT1, CASP3, ELOVL5). METHODS AND RESULTS: Three groups of in vitro bovine embryos were cultured with varying concentrations of resveratrol (0.01, 0.001, and 0.0001 µM), with a fourth group serving as a control. Following the vitrification process, embryos were categorized as either good or poor quality. Blastocysts were then preserved at - 80 °C for RNA isolation, followed by qRT-PCR analysis of selected genes. The low concentrations of resveratrol (0.001 µM, P < 0.05 and 0.0001 µM, P < 0.01) significantly improved the blastocyst rate compared to the control group. Moreover, the proportion of good quality vitrified embryos increased significantly (P < 0.05) in the groups treated with 0.001 and 0.0001 µM resveratrol compared to the control group. Analysis of gene expression showed a significant increase in OCT4 and DNMT1 transcripts in both good and poor-quality embryos treated with resveratrol compared to untreated embryos. Additionally, CASP3 expression was decreased in treated good embryos compared to control embryos. Furthermore, ELOVL5 and ATF6 transcripts were down-regulated in treated good embryos compared to the control group. Regarding antioxidant-related genes, GPX4, SOD, and CPT2 transcripts increased in the treated embryos, while NFE2L2 mRNA decreased in treated good embryos compared to the control group. CONCLUSIONS: Resveratrol supplementation at low concentrations effectively mitigated oxidative stress and enhanced the cryotolerance of embryos by modulating the expression of genes involved in oxidative stress response.


Subject(s)
Antioxidants , Blastocyst , Cryopreservation , Oxidative Stress , Resveratrol , Vitrification , Animals , Cattle , Resveratrol/pharmacology , Vitrification/drug effects , Oxidative Stress/drug effects , Oxidative Stress/genetics , Cryopreservation/methods , Antioxidants/pharmacology , Antioxidants/metabolism , Blastocyst/drug effects , Blastocyst/metabolism , Gene Expression Regulation, Developmental/drug effects , Fertilization in Vitro/veterinary , Fertilization in Vitro/methods , Embryo, Mammalian/drug effects , Embryo, Mammalian/metabolism , Embryo Culture Techniques/methods , Embryonic Development/drug effects , Embryonic Development/genetics , Oocytes/drug effects , Oocytes/metabolism , Female
9.
JBRA Assist Reprod ; 28(2): 276-283, 2024 Jun 01.
Article in English | MEDLINE | ID: mdl-38775323

ABSTRACT

OBJECTIVE: Cryopreservation has some adverse effects on embryos including cell metabolism reduction, mitochondria and plasma membrane damage, excess production of 'Reactive Oxygen Species' and damage to DNA. In the present study. In this study we assessed the effect of coenzyme Q10 as an exogenous antioxidant on mouse embryos following cryopreservation. METHODS: We collected mice embryos at the morula stage from uterine horns on the third day of gestation. The morulae were divided into 9 groups (1 control, 2 vehicles and 6 experimental), then vitrified. The culture and/or vitrification media of the experimental groups were supplemented by 10 or 30 µM of CoQ10. After one week, the embryos were warmed and then cultured. After 48 hours of embryo culture, the blastocyst rate, total cell number, viability; and after 72 hours of embryo culture, we assessed the hatching rate. RESULTS: Blastocyst rate and hatching rate were significantly reduced in the groups containing 30 µM CoQ10 supplemented culture media compared to other groups (p<0.05). The hatching rate in the groups containing 10 µM CoQ10 supplemented in both culture and vitrification media was significantly higher than in the other groups (p<0.05). In groups containing 10 µM CoQ10 supplemented culture media, the viability was higher than that in the other groups (p<0.05). CONCLUSIONS: It seems that CoQ10 in a dose-dependent manner is able to improve hatching rate and viability following cryopreservation through its antioxidant and anti-apoptotic properties, and through the production of ATP.


Subject(s)
Cryopreservation , Ubiquinone , Animals , Ubiquinone/analogs & derivatives , Ubiquinone/pharmacology , Mice , Female , Embryo Culture Techniques , Embryonic Development/drug effects , Blastocyst/drug effects , Vitrification/drug effects , Embryo, Mammalian/drug effects , Antioxidants/pharmacology , Pregnancy
10.
Theriogenology ; 226: 1-9, 2024 Sep 15.
Article in English | MEDLINE | ID: mdl-38820771

ABSTRACT

Previous studies indicate a positive correlation between the duration of estrus prior to ovulation and likelihood of pregnancy in embryo recipient mares. However, the mechanisms by which the duration of estrus before may affect fertility remains unclear. This study aimed to determine the effect of different durations of estradiol exposure, prior to progesterone administration, on embryo viability in anestrous recipient mares, and endometrial expression of genes thought to influence embryo survival. Three groups of anestrous recipient mares treated with different duration of estradiol were used: long (LE), short (SE) and no treatment (NE). Day 8 embryos were transferred into recipient mares four days after long-acting progesterone administration and recovered 48h later to examine embryo growth and viability. The endometrial gene expression profile of selected genes was also investigated. The likelihood of recovering an embryo 48h after transfer was 46.1% (6/13), 62.5% (5/8) and 85.7% (6/7) for recipient mares from the NE, SE and LE groups, respectively (P = .09). Embryos recovered from the different groups of recipients did not, however, differ in size, morphology or the proportion of nuclei undergoing mitosis (P > .05). Abundance of mRNA for uterocalin (P19) and insulin-like growth factor 1 (IGF1) were increased in the LE compared to the NE group, while fibroblast growth factor 2 (FGF2), progesterone receptor (PGR) and insulin-like growth factor 1 receptor (IGF1R) transcript abundances were increased (P < 0.05) in the NE group compared to both SE and LE groups. In conclusion, a longer exposure of the endometrium to estradiol before progesterone tended to improve embryo survival within 48h of transfer. However, the grade, growth rate, and proportion of mitotic cells in surviving embryos did not differ among groups. If embryos are destined to fail in a suboptimal endometrial environment, they die and disappear quickly. Moreover, a more adequately estradiol-primed uterus, before the progesterone rise, seems to create a uterine environment, in terms of P19, IGF1, FGF2 and PGR gene expression, more conducive to embryo survival and further development.


Subject(s)
Embryo Transfer , Endometrium , Estradiol , Animals , Female , Horses/embryology , Estradiol/pharmacology , Embryo Transfer/veterinary , Endometrium/drug effects , Endometrium/metabolism , Pregnancy , Embryo, Mammalian/drug effects , Anestrus/drug effects , Time Factors , Progesterone/pharmacology , Gene Expression Regulation, Developmental/drug effects , Embryonic Development/drug effects
11.
Food Chem Toxicol ; 188: 114633, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38608924

ABSTRACT

The cytotoxic mycotoxin deoxynivalenol (DON) reportedly has adverse effects on oocyte maturation and embryonic development in pigs. Recently, the interplay between cell apoptosis and endoplasmic reticulum (ER) stress has garnered increasing attention in embryogenesis. However, the involvement of the inositol-requiring enzyme 1 (IRE1)/c-jun N-terminal kinase (JNK)/C/EBP homologous protein (CHOP) pathways of unfolded protein response (UPR) signaling in DON-induced apoptosis in porcine embryos remains unknown. In this study, we revealed that exposure to DON (0.25 µM) substantially decreased cell viability until the blastocyst stage in porcine embryos, concomitant with initiation of cell apoptosis through the IRE1/JNK/CHOP pathways in response to ER stress. Quantitative PCR confirmed that UPR signaling-related transcription factors were upregulated in DON-treated porcine blastocysts. Western blot analysis showed that IRE1/JNK/CHOP signaling was activated in DON-exposed porcine embryos, indicating that ER stress-associated apoptosis was instigated. The ER stress inhibitor tauroursodeoxycholic acid protected against DON-induced ER stress in porcine embryos, indicating that the toxic effects of DON on early developmental competence of porcine embryos can be prevented. In conclusion, DON exposure impairs the developmental ability of porcine embryos by inducing ER stress-mediated apoptosis via IRE1/JNK/CHOP signaling.


Subject(s)
Apoptosis , Endoplasmic Reticulum Stress , Transcription Factor CHOP , Trichothecenes , Animals , Endoplasmic Reticulum Stress/drug effects , Apoptosis/drug effects , Transcription Factor CHOP/metabolism , Transcription Factor CHOP/genetics , Swine , Trichothecenes/toxicity , JNK Mitogen-Activated Protein Kinases/metabolism , JNK Mitogen-Activated Protein Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , Protein Serine-Threonine Kinases/genetics , Signal Transduction/drug effects , Embryo, Mammalian/drug effects , Unfolded Protein Response/drug effects , Blastocyst/drug effects , Blastocyst/metabolism , Female
12.
Reprod Biomed Online ; 48(5): 103763, 2024 05.
Article in English | MEDLINE | ID: mdl-38452604

ABSTRACT

RESEARCH QUESTION: Embryo blastomeres and the zona pellucida are occasionally damaged during vitrification; is this a result of crack-induced mechanical damage in the glass state, caused by external bending of the device? DESIGN: A stereomicroscope was used to observe external bending-induced cracks in a cryoprotectant. Thereafter, 309 human cleavage-stage embryos derived from abnormally fertilized eggs were used to assess embryo damage under two external bending conditions: forward bending and backward bending, with three bending degrees applied. Three distinct embryo positions were used to examine the correlation between bending and embryo damage. Damage was assessed by looking at blastomere lysis rates, and overall rates of damaged and surviving embryos. RESULTS: A series of parallel cracks were identified in the cryoprotectant used for external bending, which led to damage to the embryo blastomeres. Compared with forward bending and control, the embryos were found to be more easily damaged by backward bending, indicated by significantly higher blastomere lysis and embryo damage rates, and lower embryo survival rate of backward bending than forward bending (P < 0.001). The degree of embryo damage also increased as the degree of external forces increased. Embryo position correlated with degree of embryo damage. CONCLUSIONS: Cryoprotectant crack-induced damage was identified as the cause of embryo damage. Mechanical damage to the glass state occurs because of improper external bending of the cryodevice strip in liquid nitrogen during vitrification. To prevent damage, bending of the strip should be avoided and the embryos should be placed near the tip of the strip.


Subject(s)
Blastomeres , Cryopreservation , Cryoprotective Agents , Vitrification , Humans , Cryoprotective Agents/pharmacology , Female , Embryo, Mammalian/drug effects
13.
Biol Reprod ; 111(1): 43-53, 2024 Jul 12.
Article in English | MEDLINE | ID: mdl-38519105

ABSTRACT

A high incidence of pregnancy failures occurs in cattle during the second week of pregnancy as blastocysts transition into an elongated conceptus. This work explored whether interleukin-6 supplementation during in vitro embryo production would improve subsequent conceptus development. Bovine embryos were treated with 0 or 100 ng/mL recombinant bovine interleukin-6 beginning on day 5 post-fertilization. At day 7.5 post-fertilization, blastocysts were transferred into estrus synchronized beef cows (n = 5 recipients/treatment, 10 embryos/recipient). Seven days after transfer (day 14.5), cows were euthanized to harvest reproductive tracts and collect conceptuses. Individual conceptus lengths and stages were recorded before processing for RNA sequencing. Increases in conceptus recovery, length, and the proportion of tubular and filamentous conceptuses were detected in conceptuses derived from interleukin-6-treated embryos. The interleukin-6 treatment generated 591 differentially expressed genes in conceptuses (n = 9-10/treatment). Gene ontology enrichment analyses revealed changes in transcriptional regulation, DNA-binding, and antiviral actions. Only a few differentially expressed genes were associated with extraembryonic development, but several differentially expressed genes were associated with embryonic regulation of transcription, mesoderm and ectoderm development, organogenesis, limb formation, and somatogenesis. To conclude, this work provides evidence that interleukin-6 treatment before embryo transfer promotes pre-implantation conceptus development and gene expression in ways that resemble the generation of a robust conceptus containing favorable abilities to survive this critical period of pregnancy.


Subject(s)
Embryonic Development , Interleukin-6 , Transcriptome , Animals , Cattle , Interleukin-6/genetics , Interleukin-6/metabolism , Interleukin-6/pharmacology , Embryonic Development/drug effects , Female , Transcriptome/drug effects , Embryo Culture Techniques/veterinary , Pregnancy , Fertilization in Vitro/veterinary , Blastocyst/drug effects , Blastocyst/metabolism , Embryo Transfer/veterinary , Gene Expression Regulation, Developmental/drug effects , Embryo, Mammalian/drug effects
14.
Birth Defects Res ; 115(6): 605-613, 2023 04 01.
Article in English | MEDLINE | ID: mdl-36737400

ABSTRACT

BACKGROUND: Ondansetron is a 5HT3 receptor antagonist, used to mitigate the effects of nausea and vomiting after chemotherapy or surgery. Since nausea and vomiting are common experiences during the first trimester of pregnancy, this antiemetic has been the main drug used during this period. METHODS: To evaluate the effects of ondansetron on the embryo-fetal development, which are still very contradictory, pregnant rats were exposed to therapeutic doses of ondansetron (1.7 or 2.5 mg/kg) daily, from gestational day (GD) 6 to 15. RESULTS: No clinical signs of toxicity were observed in dams during the treatment. Although the hemato-biochemical parameters were similar among the groups, histological changes, as well as a reduction in the weight of kidney were found in the treated dams. After fetal examination, no visceral and skeletal abnormalities were observed in treated fetuses. CONCLUSION: In conclusion, therapeutic doses of ondansetron have low teratogenic potential in rats. These data provide important information about the drug safety during pregnancy.


Subject(s)
Antiemetics , Embryo, Mammalian , Ondansetron , Animals , Female , Pregnancy , Rats , Antiemetics/toxicity , Embryo, Mammalian/drug effects , Nausea/drug therapy , Ondansetron/toxicity , Vomiting/drug therapy
15.
Oxid Med Cell Longev ; 2022: 7113793, 2022.
Article in English | MEDLINE | ID: mdl-35237383

ABSTRACT

α-Ketoglutarate (α-KG) is a metabolite in the tricarboxylic acid cycle. It has a strong antioxidant function and can effectively prevent oxidative damage. Previous studies have shown that α-KG exists in porcine follicles, and its content gradually increases as the follicles grow and mature. However, the potential mechanism of supplementation of α-KG on porcine oocytes during in vitro maturation (IVM) has not yet been reported. The purpose of this study was to explore the effect of α-KG on the early embryonic development of pigs and the mechanisms underlying these effects. We found that α-KG can enhance the development of early pig embryos. Adding 20 µM α-KG to the in vitro culture medium significantly increased the rate of blastocyst formation and the total cell number. Compared with to that of the control group, apoptosis in blastocysts of the supplement group was significantly reduced. α-KG reduced the production of reactive oxygen species and glutathione levels in cells. α-KG not only improved the activity of mitochondria but also inhibited the occurrence of apoptosis. After supplementation with α-KG, pig embryo pluripotency-related genes (OCT4, NANOG, and SOX2) and antiapoptotic genes (Bcl2) were upregulated. In terms of mechanism, α-KG activates the Nrf2/ARE signaling pathway to regulate the expression of antioxidant-related targets, thus combating oxidative stress during the in vitro culture of oocytes. Activated Nrf2 promotes the transcription of Bcl2 genes and inhibits cell apoptosis. These results indicate that α-KG supplements have a beneficial effect on IVM by regulating oxidative stress during the IVM of porcine oocytes and can be used as a potential antioxidant for IVM of porcine oocytes.


Subject(s)
Antioxidants/pharmacology , Embryonic Development/drug effects , Ketoglutaric Acids/pharmacology , Meiosis/drug effects , NF-E2-Related Factor 2/metabolism , Oocytes/metabolism , Oogenesis/drug effects , Oxidative Stress/drug effects , Signal Transduction/drug effects , Animals , Apoptosis/drug effects , Blastocyst/metabolism , Culture Media/chemistry , Dietary Supplements , Embryo, Mammalian/drug effects , Embryo, Mammalian/metabolism , Female , Glutathione/metabolism , In Vitro Oocyte Maturation Techniques/methods , Mitochondria/metabolism , Oocytes/drug effects , Pregnancy , Reactive Oxygen Species/metabolism , Swine
16.
Int J Mol Sci ; 23(4)2022 Feb 15.
Article in English | MEDLINE | ID: mdl-35216252

ABSTRACT

Mosaicism is the most important limitation for one-step gene editing in embryos by CRISPR/Cas9 because cuts and repairs sometimes take place after the first DNA replication of the zygote. To try to minimize the risk of mosaicism, in this study a reversible DNA replication inhibitor was used after the release of CRISPR/Cas9 in the cell. There is no previous information on the use of aphidicolin in porcine embryos, so the reversible inhibition of DNA replication and the effect on embryo development of different concentrations of this drug was first evaluated. The effect of incubation with aphidicolin was tested with CRISPR/Cas9 at different concentrations and different delivery methodologies. As a result, the reversible inhibition of DNA replication was observed, and it was concentration dependent. An optimal concentration of 0.5 µM was established and used for subsequent experiments. Following the use of this drug with CRISPR/Cas9, a halving of mosaicism was observed together with a detrimental effect on embryo development. In conclusion, the use of reversible inhibition of DNA replication offers a way to reduce mosaicism. Nevertheless, due to the reduction in embryo development, it would be necessary to reach a balance for its use to be feasible.


Subject(s)
Aphidicolin/pharmacology , CRISPR-Cas Systems/drug effects , Cell Nucleus/drug effects , DNA Replication/drug effects , Embryo, Mammalian/drug effects , Eukaryota/drug effects , Animals , Animals, Genetically Modified , Embryonic Development/drug effects , Gene Editing/methods , Mosaicism/drug effects , Swine , Zygote/drug effects
17.
J Appl Toxicol ; 42(3): 380-391, 2022 03.
Article in English | MEDLINE | ID: mdl-34322893

ABSTRACT

This report introduces a novel method, rabbit whole embryo culture (WEC) combined with toxicokinetics (TK), for toxicity testing. Rodent WEC has been extensively used for in vitro screening of developmental toxicity. To improve the reliability of in vitro data, it is important to consider TK and species specificity. To test the utility and effectiveness of this method, we investigated the toxic effect of thalidomide on rabbit embryos and its behavior in test systems both in vitro and in vivo under the same experimental condition. The data showed that thalidomide induced embryo malformations such as embryonic brain hypoplasia, short limb buds, and declined embryonic growth both in vitro and in vivo. The toxic effect increased with the increasing exposure of the embryo to thalidomide. In addition, we observed similar toxic effects and exposure-effect relationships in vivo and in vitro. Therefore, we preliminarily conclude that this new method can effectively predict and explain thalidomide toxicity. Furthermore, we investigated the behavior of test compounds in the WEC system for the first time, and this method is expected to be an important technique for in vitro toxicity study after extensive verification.


Subject(s)
Embryo, Mammalian/drug effects , In Vitro Techniques/methods , Teratogens/toxicity , Toxicity Tests/methods , Toxicokinetics , Animals , Rabbits , Reproducibility of Results , Toxicity Tests/instrumentation
18.
PLoS One ; 16(12): e0260123, 2021.
Article in English | MEDLINE | ID: mdl-34882691

ABSTRACT

Serum supplementation during bovine embryo culture has been demonstrated to promote cell proliferation and preimplantation embryo development. However, these desirable outcomes, have been associated with gene expression alterations of pathways involved in macroautophagy, growth, and development at the blastocyst stage, as well as with developmental anomalies such as fetal overgrowth and placental malformations. In order to start dissecting the molecular pathways by which serum supplementation of the culture medium during the preimplantation stage promotes developmental abnormalities, we examined blastocyst morphometry, inner cell mass and trophectoderm cell allocations, macroautophagy, and endoplasmic reticulum stress. On day 5 post-insemination, > 16 cells embryos were selected and cultured in medium containing 10% serum or left as controls. Embryo diameter, inner cell mass and trophectoderm cell number, and macroautophagy were measured on day 8 blastocysts (BL) and expanded blastocysts (XBL). On day 5 and day 8, we assessed transcript level of the ER stress markers HSPA5, ATF4, MTHFD2, and SHMT2 as well as XBP1 splicing (a marker of the unfolded protein response). Serum increased diameter and proliferation of embryos when compared to the no-serum group. In addition, serum increased macroautophagy of BL when compared to controls, while the opposite was true for XBL. None of the genes analyzed was differentially expressed at any stage, except that serum decreased HSPA5 in day 5 > 16 cells stage embryos. XBP1 splicing was decreased in BL when compared to XBL, but only in the serum group. Our data suggest that serum rescues delayed embryos by alleviating endoplasmic reticulum stress and promotes development of advanced embryos by decreasing macroautophagy.


Subject(s)
Culture Media/pharmacology , Embryo, Mammalian/cytology , Genetic Markers/drug effects , Serum/chemistry , Animals , Blastocyst , Cattle , Cell Proliferation/drug effects , Culture Media/chemistry , Embryo Culture Techniques , Embryo, Mammalian/drug effects , Embryo, Mammalian/metabolism , Embryonic Development/drug effects , Endoplasmic Reticulum Stress , Gene Expression Regulation, Developmental , Macroautophagy/drug effects
19.
Stem Cell Reports ; 16(11): 2674-2689, 2021 11 09.
Article in English | MEDLINE | ID: mdl-34678203

ABSTRACT

Pig cloning by somatic cell nuclear transfer (SCNT) frequently undergoes incomplete epigenetic remodeling during the maternal-to-zygotic transition, which leads to a significant embryonic loss before implantation. Here, we generated the first genome-wide landscapes of histone methylation in pig SCNT embryos. Excessive H3K9me3 and H3K27me3, but not H3K4me3, were observed in the genomic regions with unfaithful embryonic genome activation and donor-cell-specific gene silencing. A combination of H3K9 demethylase KDM4A and GSK126, an inhibitor of H3K27me3 writer, were able to remove these epigenetic barriers and restore the global transcriptome in SCNT embryos. More importantly, thymine DNA glycosylase (TDG) was defined as a pig-specific epigenetic regulator for nuclear reprogramming, which was not reactivated by H3K9me3 and H3K27me3 removal. Both combined treatment and transient TDG overexpression promoted DNA demethylation and enhanced the blastocyst-forming rates of SCNT embryos, thus offering valuable methods to increase the cloning efficiency of genome-edited pigs for agricultural and biomedical purposes.


Subject(s)
Embryo, Mammalian/metabolism , Epigenesis, Genetic , Gene Expression Regulation , Histones/metabolism , Nuclear Transfer Techniques , Thymine DNA Glycosylase/genetics , Animals , Blastocyst/cytology , Blastocyst/metabolism , DNA Methylation , Demethylation , Embryo, Mammalian/drug effects , Embryo, Mammalian/embryology , Gene Expression Profiling/methods , Histone Demethylases/genetics , Histone Demethylases/metabolism , Indoles/pharmacology , Lysine/metabolism , Methylation , Pyridones/pharmacology , Swine , Thymine DNA Glycosylase/metabolism
20.
Biol Reprod ; 105(6): 1427-1442, 2021 12 20.
Article in English | MEDLINE | ID: mdl-34617564

ABSTRACT

During preimplantational embryo development, PI3K/AKT regulates cell proliferation and differentiation and nobiletin modulates this pathway to promote cell survival. Therefore, we aimed to establish whether, when the AKT cascade is inhibited using inhibitors III and IV, nobiletin supplementation to in vitro culture media during the minor (2- to 8-cell stage, MNEGA) or major (8- to 16-cell stage, MJEGA) phases of EGA is able to modulate the development and quality of bovine embryos. In vitro zygotes were cultured during MNEGA or MJEGA phase in SOF + 5% FCS or supplemented with: 15 µM AKT-InhIII; 10 µM AKT-InhIV; 10 µM nobiletin; nobiletin + AKT-InhIII; nobiletin + AKT-InhIV; 0.03% DMSO. Embryo development was lower in treatments with AKT inhibitors, while combination of nobiletin with AKT inhibitors was able to recover their adverse developmental effect and also increase blastocyst cell number. The mRNA abundance of GPX1, NFE2L2, and POU5F1 was partially increased in 8- and 16-cell embryos from nobiletin with AKT inhibitors. Besides, nobiletin increased the p-rpS6 level whether or not AKT inhibitors were present. In conclusion, nobiletin promotes bovine embryo development and quality and partially recovers the adverse developmental effect of AKT inhibitors, which infers that nobiletin probably uses another signaling cascade that PI3K/AKT during early embryo development in bovine.


Subject(s)
Antioxidants/pharmacology , Cattle/embryology , Embryo, Mammalian/drug effects , Embryonic Development/drug effects , Flavones/pharmacology , Proto-Oncogene Proteins c-akt/antagonists & inhibitors , Animals , Embryo, Mammalian/embryology
SELECTION OF CITATIONS
SEARCH DETAIL